Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 09, 2014 07:35 ET | Source: MYOS Corporation

MYOS Corporation Studies Muscle and Strength Building Activity of Fortetropin in Resistance Trained Male Subjects

CEDAR KNOLLS, NJ--(Marketwired - Apr 9, 2014) - MYOS Corporation ("MYOS" or the "Company") (OTCBB: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development...
April 01, 2014 07:35 ET | Source: MYOS Corporation

MYOS Corporation Reports 2013 Fourth Quarter and Full Year Results

CEDAR KNOLLS, NJ--(Marketwired - Apr 1, 2014) - MYOS Corporation (OTCBB: MYOS) Company Demonstrates Solid Market Expansion and Growth with 276% Increase in Gross...
March 27, 2014 07:35 ET | Source: MYOS Corporation

MYOS Corporation Joins Scientific Working Group Aging in Motion to Develop Patient Centered Treatment Measures for Sarcopenia

CEDAR KNOLLS, NJ--(Marketwired - Mar 27, 2014) - MYOS Corporation (OTCBB: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of...
March 17, 2014 08:05 ET | Source: MYOS Corporation

MYOS Corporation Takes Steps to Make a Difference in the Fight Against Muscle Disease at the New Jersey MDA Muscle Walk

CEDAR KNOLLS, NJ--(Marketwired - Mar 17, 2014) - MYOS Corporation (OTCBB: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of...
March 12, 2014 08:05 ET | Source: MYOS Corp

MYOS Corporation to Present Abstract on Lipidomic and Proteomic Studies of MYO-T12(R) at the International Conference on Frailty and Sarcopenia Research

CEDAR KNOLLS, NJ--(Marketwired - Mar 12, 2014) - MYOS Corporation (OTCBB: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of...
February 27, 2014 08:05 ET | Source: MYOS Corp

MYOS Corporation Initiates Clinical Study of MYO-T12(R) in Adult Women

CEDAR KNOLLS, NJ--(Marketwired - Feb 27, 2014) - MYOS Corporation (OTCBB: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of...
February 24, 2014 08:05 ET | Source: MYOS Corp

MYOS Corporation Appoints Christopher Pechock to Its Board of Directors

CEDAR KNOLLS, NJ--(Marketwired - Feb 24, 2014) - MYOS Corporation (OTCBB: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of...
February 13, 2014 07:35 ET | Source: MYOS Corp

MYOS Corporation Announces Appointment of Robert C. Ashton, Jr., M.D., as Chief Medical Officer

CEDAR KNOLLS, NJ--(Marketwired - Feb 13, 2014) - MYOS Corporation (OTCBB: MYOSD), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of...
February 10, 2014 07:35 ET | Source: MYOS Corp

MYOS Board of Directors Issues Letter to Shareholders

CEDAR KNOLLS, NJ--(Marketwired - Feb 10, 2014) - MYOS Corporation (OTCBB: MYOSD), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of...
February 10, 2014 07:30 ET | Source: MYOS Corp

MYOS Corporation Announces 1-for-50 Reverse Stock Split Following Five Consecutive Quarters of Market Expansion and Revenue Growth

CEDAR KNOLLS, NJ--(Marketwired - Feb 10, 2014) - MYOS Corporation (OTCBB: MYOSD), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right